Acute exposure to fine ambient particulate matter and pulmonary exacerbations in cystic fibrosis: A case-crossover study
Open Access
- 24 January 2026
- journal article
- Published by Elsevier in Atmospheric Environment: X
- Vol. 29
Abstract
No abstract availableKeywords
Funding Information
- U.S. National Library of Medicine (R01LM013222)
- National Institute of Environmental Health Sciences
- National Institute of Ecology (T32ES010957)
- National Heart, Lung, and Blood Institute (R01HL141286)
- Cystic Fibrosis Foundation (AMIN24R0)
This publication has 31 references indexed in Scilit:
- Update on the diagnosis and management of cystic fibrosis pulmonary exacerbationsJournal of Cystic Fibrosis, 2024
- Evaluating FEV1 decline in diagnosis and management of pulmonary exacerbations in children with cystic fibrosisPediatric Pulmonology, 2022
- A high resolution spatiotemporal fine particulate matter exposure assessment model for the contiguous United StatesEnvironmental Advances, 2022
- Acute Pulmonary Exacerbations in Cystic FibrosisSeminars in Respiratory and Critical Care Medicine, 2019
- Improving and monitoring air qualityEnvironmental Science and Pollution Research, 2018
- Standardized Treatment of Pulmonary Exacerbations (STOP) study: Observations at the initiation of intravenous antibiotics for cystic fibrosis pulmonary exacerbationsJournal of Cystic Fibrosis, 2017
- Respiratory pathogens mediate the association between lung function and temperature in cystic fibrosisJournal of Cystic Fibrosis, 2016
- Quantifying the magnitude of environmental exposure misclassification when using imprecise address proxies in public health researchSpatial and Spatio-temporal Epidemiology, 2012
- Quantification of the Relative Contribution of Environmental and Genetic Factors to Variation in Cystic Fibrosis Lung FunctionThe Journal of Pediatrics, 2010
- Within‐subject exposure dependency in case‐crossover studiesStatistics in Medicine, 2001